1 |
Tommasi C, Pellegrino B, Diana A, Palafox Sancez M, Orditura M, Scartozzi M, Musolino A, Solinas C. The Innate Immune Microenvironment in Metastatic Breast Cancer. JCM 2022;11:5986. [DOI: 10.3390/jcm11205986] [Reference Citation Analysis]
|
2 |
Hulin Chang, Lei Jin, Peiyi Xie, Bo Zhang, Mincheng Yu, Hui Li, Shuang Liu, Jiuliang Yan, Binghai Zhou, Xiaoqiang Li, Yongfeng Xu, Yongsheng Xiao, Qinghai Ye, Lei Guo. Complement C5 is a novel biomarker for liver metastasis of colorectal cancer. J Gastrointest Oncol 2022;13. [PMID: 36388659 DOI: 10.21037/jgo-22-829] [Reference Citation Analysis]
|
3 |
Gorman DM, Li XX, Lee JD, Fung JN, Cui CS, Lee HS, Rolfe BE, Woodruff TM, Clark RJ. Development of Potent and Selective Agonists for Complement C5a Receptor 1 with In Vivo Activity. J Med Chem 2021;64:16598-608. [PMID: 34762432 DOI: 10.1021/acs.jmedchem.1c01174] [Reference Citation Analysis]
|
4 |
Taylor RP. Special Issue: The Role of Complement in Cancer Immunotherapy. Antibodies (Basel) 2021;10:29. [PMID: 34449550 DOI: 10.3390/antib10030029] [Reference Citation Analysis]
|
5 |
H. KN, F. BN, Noor MHM. Modulation of C5a-C5aR interactions against murine mammary cancer cell line. Comp Clin Pathol 2021;30:549-557. [DOI: 10.1007/s00580-021-03249-6] [Reference Citation Analysis]
|
6 |
Zhang Y, Chen X, Cao Y, Yang Z. C8B in Complement and Coagulation Cascades Signaling Pathway is a predictor for Survival in HBV-Related Hepatocellular Carcinoma Patients. Cancer Manag Res 2021;13:3503-15. [PMID: 33911900 DOI: 10.2147/CMAR.S302917] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
|